Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Legendre

Showing results (51-60 of 456) with videos related to

Pageof 46
Sort By:
Kidney International|August 25, 2016
Antiphospholipid syndrome and kidney diseaseFrank Bienaimé, Christophe Legendre, Fabiola Terzi, et al.
Medecine Sciences : M/S|June 1, 2010
[Living donors for kidney transplantation: ethical and legal challenges]Marie-France Mamzer-Bruneel, Catherine Fournier, Christophe Legendre
Current Drug Safety|August 12, 2008
Sirolimus early graft nephrotoxicity: clinical and experimental dataNicolas Pallet, Eric Thervet, Christophe Legendre, et al.
Nephrologie & Therapeutique|April 3, 2018
[Identifying the specific causes of kidney allograft loss: A population-based study]Charlotte Lohéac, Olivier Aubert, Alexandre Loupy, et al.
Nucleic Acids Research|June 23, 2007
BIPASS: BioInformatics Pipeline Alternative Splicing ServicesZoé Lacroix, Christophe Legendre, Louiqa Raschid, et al.
Current Opinion in Organ Transplantation|October 6, 2011
Harnessing regulatory T cells for transplant tolerance in the clinic through mTOR inhibition: myth or reality?Julien Zuber, Olivier Hermine, Lucienne Chatenoud, et al.
Therapeutic Drug Monitoring|March 28, 2008
Role of pharmacogenetics of immunosuppressive drugs in organ transplantationEric Thervet, Dany Anglicheau, Christophe Legendre, et al.
Frontiers in Immunology|November 16, 2020
Editorial: Transplantation of Marginal Organs-Immunological Aspects and Therapeutic PerspectivesCaner Süsal, Thomas Friedrich Mueller, Christophe Legendre, et al.
Transplantation|February 15, 2017
HIV Infection in the Native and Allograft Kidney: Implications for Management, Diagnosis, and TransplantationVéronique Avettand-Fenoël, Christine Rouzioux, Christophe Legendre, et al.
Clinical Transplants|June 8, 2010
Bortezomib alone fails to decrease donor specific anti-HLA antibodies: 4 case reportsRebecca Sberro-Soussan, Julien Zuber, Caroline Suberbielle-Boissel, et al.
Pageof 46

Showing results (51-60 of 456) with videos related to

Sort By:
Pageof 46
Kidney International|August 25, 2016
Antiphospholipid syndrome and kidney diseaseFrank Bienaimé, Christophe Legendre, Fabiola Terzi, et al.
Medecine Sciences : M/S|June 1, 2010
[Living donors for kidney transplantation: ethical and legal challenges]Marie-France Mamzer-Bruneel, Catherine Fournier, Christophe Legendre
Current Drug Safety|August 12, 2008
Sirolimus early graft nephrotoxicity: clinical and experimental dataNicolas Pallet, Eric Thervet, Christophe Legendre, et al.
Nephrologie & Therapeutique|April 3, 2018
[Identifying the specific causes of kidney allograft loss: A population-based study]Charlotte Lohéac, Olivier Aubert, Alexandre Loupy, et al.
Nucleic Acids Research|June 23, 2007
BIPASS: BioInformatics Pipeline Alternative Splicing ServicesZoé Lacroix, Christophe Legendre, Louiqa Raschid, et al.
Current Opinion in Organ Transplantation|October 6, 2011
Harnessing regulatory T cells for transplant tolerance in the clinic through mTOR inhibition: myth or reality?Julien Zuber, Olivier Hermine, Lucienne Chatenoud, et al.
Therapeutic Drug Monitoring|March 28, 2008
Role of pharmacogenetics of immunosuppressive drugs in organ transplantationEric Thervet, Dany Anglicheau, Christophe Legendre, et al.
Frontiers in Immunology|November 16, 2020
Editorial: Transplantation of Marginal Organs-Immunological Aspects and Therapeutic PerspectivesCaner Süsal, Thomas Friedrich Mueller, Christophe Legendre, et al.
Transplantation|February 15, 2017
HIV Infection in the Native and Allograft Kidney: Implications for Management, Diagnosis, and TransplantationVéronique Avettand-Fenoël, Christine Rouzioux, Christophe Legendre, et al.
Clinical Transplants|June 8, 2010
Bortezomib alone fails to decrease donor specific anti-HLA antibodies: 4 case reportsRebecca Sberro-Soussan, Julien Zuber, Caroline Suberbielle-Boissel, et al.
Pageof 46